These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17506540)

  • 1. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
    Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
    J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.
    Jozwiak K; Woo AY; Tanga MJ; Toll L; Jimenez L; Kozocas JA; Plazinska A; Xiao RP; Wainer IW
    Bioorg Med Chem; 2010 Jan; 18(2):728-36. PubMed ID: 20036561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
    Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
    Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
    Plazinska A; Kolinski M; Wainer IW; Jozwiak K
    J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.
    Woo AY; Wang TB; Zeng X; Zhu W; Abernethy DR; Wainer IW; Xiao RP
    Mol Pharmacol; 2009 Jan; 75(1):158-65. PubMed ID: 18838481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
    Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
    Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
    Reinartz MT; Kälble S; Wainer IW; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
    Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
    Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.
    Plazinska A; Pajak K; Rutkowska E; Jimenez L; Kozocas J; Koolpe G; Tanga M; Toll L; Wainer IW; Jozwiak K
    Bioorg Med Chem; 2014 Jan; 22(1):234-46. PubMed ID: 24326276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
    Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
    Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective binding of agonists to the β
    Plazinska A; Plazinski W
    Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimerization With 5-HT
    Song Y; Xu C; Liu J; Li Y; Wang H; Shan D; Wainer IW; Hu X; Zhang Y; Woo AY; Xiao RP
    Circ Res; 2021 Jan; 128(2):262-277. PubMed ID: 33208036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
    Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
    J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
    Plazinska A; Plazinski W; Jozwiak K
    J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.
    Jozwiak K; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
    Biochem Pharmacol; 2010 Jun; 79(11):1610-5. PubMed ID: 20144591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.
    Reinartz MT; Kälble S; Littmann T; Ozawa T; Dove S; Kaever V; Wainer IW; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):51-65. PubMed ID: 25342094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemical and conformational study on fenoterol by ECD spectroscopy and TD-DFT calculations.
    Tedesco D; Zanasi R; Wainer IW; Bertucci C
    J Pharm Biomed Anal; 2014 Mar; 91():92-6. PubMed ID: 24441217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
    Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
    J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
    Wnorowski A; Sadowska M; Paul RK; Singh NS; Boguszewska-Czubara A; Jimenez L; Abdelmohsen K; Toll L; Jozwiak K; Bernier M; Wainer IW
    Cell Signal; 2015 May; 27(5):997-1007. PubMed ID: 25703025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.